Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer

Gynecologic Oncology

Volumn 127, Issue 2, 2012, Pages 321-325

  Kiess, Ana P ^a   Damast, Shari ^a   Makker, Vicky ^a   Kollmeier, Marisa A ^a   Gardner, Ginger J ^a   Aghajanian, Carol ^a   Abu Rustum, Nadeem R ^a   Barakat, Richard R ^a   Alektiar, Kaled M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Brachytherapy; Chemotherapy; Intravaginal radiation; Papillary serous; Serous; Uterine cancer

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; ALLERGY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEARING IMPAIRMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION; LEG EDEMA; LUNG TOXICITY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; MUSCULOSKELETAL TOXICITY; NEPHROTOXICITY; NEUROPATHY; NEUTROPENIA; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; RADIATION DOSE FRACTIONATION; RASH; TINNITUS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; UTERUS CARCINOMA; VAGINAL TOXICITY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARBOPLATIN; CHEMORADIOTHERAPY, ADJUVANT; CYSTADENOCARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; DRUG ADMINISTRATION SCHEDULE; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM STAGING; OVARIECTOMY; PACLITAXEL; RETROSPECTIVE STUDIES; SALPINGECTOMY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84867399694     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.07.112     Document Type: Conference Paper

References (22)

1. D.M. Boruta II, P.A. Gehrig, A.N. Fader, and A.B. Olawaiye Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review Gynecol Oncol 115 2009 142 153
2. C.A. Hamilton, M.K. Cheung, K. Osann, L. Chen, N.N. Teng, and T.A. Longacre Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers Br J Cancer 94 2006 642 646
3. W.K. Huh, M. Powell, C.A. Leath III, J.M. Straughn Jr., D.E. Cohn, and M.A. Gold Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy Gynecol Oncol 91 2003 470 475
4. A.N. Fader, R.D. Drake, D.M. O'Malley, H.E. Gibbons, W.K. Huh, and L.J. Havrilesky Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma Cancer 115 2009 2119 2127
5. A.N. Fader, C. Nagel, A.E. Axtell, K.M. Zanotti, J.L. Kelley, and K.N. Moore Stage II uterine papillary serous carcinoma: carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes Gynecol Oncol 112 2009 558 562
6. M.G. Kelly, D.M. O'Malley, P. Hui, J. McAlpine, H. Yu, and T.J. Rutherford Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy Gynecol Oncol 98 2005 353 359
7. H. Goldberg, R.C. Miller, R. Abdah-Bortnyak, M. Steiner, F. Yildiz, and A. Meirovitz Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN) Gynecol Oncol 108 2008 298 305
8. L.J. Havrilesky, A.A. Secord, V. Bae-Jump, T. Ayeni, B. Calingaert, and D.L. Clarke-Pearson Outcomes in surgical stage I uterine papillary serous carcinoma Gynecol Oncol 105 2007 677 682
9. C.S. Dietrich III, S.C. Modesitt, P.D. DePriest, F.R. Ueland, J. Wilder, and M.B. Reedy The efficacy of adjuvant platinum-based chemotherapy in stage I uterine papillary serous carcinoma (UPSC) Gynecol Oncol 99 2005 557 563
10. A.N. Viswanathan, E.A. Macklin, R. Berkowitz, and U. Matulonis The importance of chemotherapy and radiation in uterine papillary serous carcinoma Gynecol Oncol 123 2011 542 547
11. K.M. Alektiar, V. Makker, N.R. Abu-Rustum, R.A. Soslow, D.S. Chi, and R.R. Barakat Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer Gynecol Oncol 112 2009 142 145
12. B.C. Turner, J.P. Knisely, B.M. Kacinski, B.G. Haffty, A.A. Gumbs, and K.B. Roberts Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy Int J Radiat Oncol Biol Phys 40 1998 77 84
13. B.G. Sorbe, and A.C. Smeds Postoperative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma stage I Int J Radiat Oncol Biol Phys 18 1990 305 314
14. NCCN Clinical Practice Guidelines in Oncology Uterine neoplasms, version 3.2012 2012 National Comprehensive Cancer Network
15. A.N. Fader, D. Starks, P.A. Gehrig, A.A. Secord, H.E. Frasure, and D.M. O'Malley An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC) Gynecol Oncol 115 2009 244 248
16. D. Abramovich, M. Markman, A. Kennedy, K. Webster, and J. Belinson Serum CA-125 as a marker of disease activity in uterine papillary serous carcinoma J Cancer Res Clin Oncol 125 1999 697 698
17. A.B. Olawaiye, J.A. Rauh-Hain, M. Withiam-Leitch, B. Rueda, A. Goodman, and M.G. del Carmen Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma Gynecol Oncol 110 2008 293 298
18. F.V. Price, S.K. Chambers, M.L. Carcangiu, E.I. Kohorn, P.E. Schwartz, and J.T. Chambers CA 125 may not reflect disease status in patients with uterine serous carcinoma Cancer 82 1998 1720 1725
19. B. DuBeshter, K. Estler, K. Altobelli, S. McDonald, C. Glantz, and C. Angel High-dose rate brachytherapy for stage I/II papillary serous or clear cell endometrial cancer Gynecol Oncol 94 2004 383 386
20. J.S. Low, E.H. Wong, H.S. Tan, S.P. Yap, E.J. Chua, and V.K. Sethi Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma Gynecol Oncol 97 2005 171 177
21. R.A. Nout, V.T. Smit, H. Putter, I.M. Jurgenliemk-Schulz, J.J. Jobsen, and L.C. Lutgens Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 2010 816 823
22. M.H. Einstein, M. Frimer, D.Y. Kuo, L.L. Reimers, K. Mehta, and S. Mutyala Phase II trial of adjuvant pelvic radiation sandwiched between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma Gynecol Oncol 124 2012 21 25